{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:46:47Z","timestamp":1791269207430,"version":"4.1.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background:<\/jats:title>\n                  <jats:p>Cardiac allograft vasculopathy (CAV) continues to be a limiting factor in long-term survival of heart transplant recipients (HTRs). Pathophysiologic and immunologic factors affecting CAV are complex, and criteria for early diagnosis remain elusive.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods:<\/jats:title>\n                  <jats:p>We performed a retrospective analysis of the relationship between donor-specific antibody (DSA), C4d immunofluorescence, and the development of CAV.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>We evaluated 330 endomyocardial biopsy (EMB) specimens from 112 cardiac grafts. Twenty-four (21%) of 112 grafts developed CAV, and 18 (75%) of 24 were positive for C4d. Patients with DSA (n = 51) against human leukocyte antigen class I (n = 5), II (n = 26), or both (n = 20) developed CAV at a rate of 40%, 38%, and 20% and a mean time to CAV of 89, 47, and 25 months, respectively. Of 61 grafts without DSA, only 13% developed CAV, with a mean time to CAV of 116 months.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions:<\/jats:title>\n                  <jats:p>Compared with the general HTR population, patients with graft dysfunction and DSA or positive C4d on EMB show a statistically significant increased incidence of CAV and allograft failure, suggesting an antibody-mediated injury. The presence of pre- and posttransplant DSA, even in the absence of positive C4d immunofluorescence, may identify a group of HTRs at increased risk of developing CAV.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1309\/ajcptlbeu5bq8shn","type":"journal-article","created":{"date-parts":[[2014,11,11]],"date-time":"2014-11-11T20:19:20Z","timestamp":1415737160000},"page":"809-815","source":"Crossref","is-referenced-by-count":47,"title":["Circulating Donor-Specific Anti\u2013Human Leukocyte Antigen Antibodies and Complement C4d Deposition Are Associated With the Development of Cardiac Allograft Vasculopathy"],"prefix":"10.1093","volume":"142","author":[{"given":"Renee","family":"Frank","sequence":"first","affiliation":[{"name":"1Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria R.","family":"Molina","sequence":"additional","affiliation":[{"name":"2Heart Failure and Cardiac Transplant Program, Division of Cardiovascular Medicine, University of Pennsylvania, Philadelphia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee R.","family":"Goldberg","sequence":"additional","affiliation":[{"name":"2Heart Failure and Cardiac Transplant Program, Division of Cardiovascular Medicine, University of Pennsylvania, Philadelphia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce W.","family":"Wald","sequence":"additional","affiliation":[{"name":"2Heart Failure and Cardiac Transplant Program, Division of Cardiovascular Medicine, University of Pennsylvania, Philadelphia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malek","family":"Kamoun","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priti","family":"Lal","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,12,1]]},"reference":[{"key":"2023012005501663400_b1-1420809","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.healun.2010.08.007","article-title":"The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report\u20142010","volume":"29","author":"Stehlik","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"2023012005501663400_b2-1420809","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1399-0012.2010.01307.x","article-title":"Cardiac allograft vasculopathy: current knowledge and future direction","volume":"25","author":"Colvin-Adams","year":"2011","journal-title":"Clin Transplant"},{"key":"2023012005501663400_b3-1420809","doi-asserted-by":"crossref","first-page":"E111","DOI":"10.1111\/j.1399-0012.2011.01565.x","article-title":"Factors associated with the development of cardiac allograft vasculopathy\u2014a systematic review of observational studies","volume":"26","author":"Braga","year":"2012","journal-title":"Clin Transplant"},{"key":"2023012005501663400_b4-1420809","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1111\/j.1600-6143.2007.01900.x","article-title":"Acute antibody-mediated rejection following heart transplantation","volume":"7","author":"Uber","year":"2007","journal-title":"Am J Transplant"},{"key":"2023012005501663400_b5-1420809","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1600-6143.2006.01644.x","article-title":"Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival","volume":"7","author":"Terasaki","year":"2007","journal-title":"Am J Transplant"},{"key":"2023012005501663400_b6-1420809","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.healun.2011.02.015","article-title":"The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: evolution and current status (2005\u20132011)","volume":"30","author":"Berry","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"2023012005501663400_b7-1420809","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.healun.2008.01.019","article-title":"Outcome of heart transplants 15 to 20 years ago: graft survival, post-transplant morbidity, and risk factors for mortality","volume":"27","author":"Roussel","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"2023012005501663400_b8-1420809","first-page":"744","article-title":"Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database","volume":"17","author":"Costanzo","year":"1998","journal-title":"J Heart Lung Transplant"},{"key":"2023012005501663400_b9-1420809","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.healun.2010.05.017","article-title":"International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy\u20142010","volume":"29","author":"Mehra","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"2023012005501663400_b10-1420809","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1006\/clim.2001.5038","article-title":"Autoimmune-mediated vasculopathy","volume":"100","author":"Chen","year":"2001","journal-title":"Clin Immunol"},{"key":"2023012005501663400_b11-1420809","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1345\/aph.1D535","article-title":"Dyslipidemias and HMG-CoA reductase inhibitor prescription in heart transplant recipients","volume":"38","author":"de Denus","year":"2004","journal-title":"Ann Pharmacother"},{"key":"2023012005501663400_b12-1420809","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1399-0012.2005.00441.x","article-title":"The impact of overweight on the development of diabetes after heart transplantation","volume":"20","author":"Kahn","year":"2006","journal-title":"Clin Transplant"},{"key":"2023012005501663400_b13-1420809","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0002-9149(89)90535-3","article-title":"Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection","volume":"64","author":"McDonald","year":"1989","journal-title":"Am J Cardiol"},{"key":"2023012005501663400_b14-1420809","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.healun.2005.03.019","article-title":"Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection","volume":"24","author":"Stewart","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"2023012005501663400_b15-1420809","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.healun.2013.08.011","article-title":"The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation","volume":"32","author":"Berry","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"2023012005501663400_b16-1420809","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.healun.2009.12.018","article-title":"Deposition of C4d and C3d in cardiac transplants: a factor in the development of coronary artery vasculopathy","volume":"29","author":"Moseley","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"2023012005501663400_b17-1420809","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.healun.2005.11.449","article-title":"The cumulative effect of acute rejection on development of cardiac allograft vasculopathy","volume":"25","author":"Stoica","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"2023012005501663400_b18-1420809","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3909\/ricm0578","article-title":"Cardiac allograft vasculopathy","volume":"12","author":"Lee","year":"2011","journal-title":"Rev Cardiovasc Med"},{"key":"2023012005501663400_b19-1420809","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.healun.2010.10.009","article-title":"Endothelitis in cardiac allograft biopsy specimens: possible relationship to antibody-mediated rejection","volume":"30","author":"Tavora","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"2023012005501663400_b20-1420809","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1600-6143.2011.03836.x","article-title":"A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody","volume":"12","author":"Hirohashi","year":"2012","journal-title":"Am J Transplant"},{"key":"2023012005501663400_b21-1420809","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.healun.2008.09.012","article-title":"A clinical correlation study of severity of antibody-mediated rejection and cardiovascular mortality in heart transplantation","volume":"28","author":"Kfoury","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"2023012005501663400_b22-1420809","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1600-6143.2011.03563.x","article-title":"Very late heart transplant rejection is associated with microvascular injury, complement deposition and progression to cardiac allograft vasculopathy","volume":"11","author":"Loupy","year":"2011","journal-title":"Am J Transplant"},{"key":"2023012005501663400_b23-1420809","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.healun.2009.01.015","article-title":"Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes","volume":"28","author":"Wu","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"2023012005501663400_b24-1420809","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.healun.2012.12.005","article-title":"Correlation of circulating donor-specific anti-HLA antibodies and presence of C4d in endomyocardial biopsy with heart allograft outcomes: a single-center, retrospective study","volume":"32","author":"Frank","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"2023012005501663400_b25-1420809","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/j.1600-6143.2004.00500.x","article-title":"National conference to assess antibody-mediated rejection in solid organ transplantation","volume":"4","author":"Takemoto","year":"2004","journal-title":"Am J Transplant"},{"key":"2023012005501663400_b26-1420809","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1600-6143.2010.03383.x","article-title":"De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival","volume":"11","author":"Smith","year":"2011","journal-title":"Am J Transplant"},{"key":"2023012005501663400_b27-1420809","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1600-6143.2004.00348.x","article-title":"Beyond C4d: other complement-related diagnostic approaches to antibody-mediated rejection","volume":"4","author":"Baldwin","year":"2004","journal-title":"Am J Transplant"},{"key":"2023012005501663400_b28-1420809","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nri1702","article-title":"Antibody-mediated organ-allograft rejection","volume":"5","author":"Colvin","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"2023012005501663400_b29-1420809","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/TP.0b013e3181fd97f1","article-title":"Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients","volume":"90","author":"Reinsmoen","year":"2010","journal-title":"Transplantation"},{"key":"2023012005501663400_b30-1420809","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/01.TP.0000436927.08026.a8","article-title":"Increased negative impact of donor HLA-specific together with non-HLA-specific antibodies on graft outcome","volume":"97","author":"Reinsmoen","year":"2014","journal-title":"Transplantation"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/142\/6\/809\/48794480\/ajcp_142_6_809.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/142\/6\/809\/48794480\/ajcp_142_6_809.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T05:51:28Z","timestamp":1674193888000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/142\/6\/809\/1766804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,1]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,12,1]]},"published-print":{"date-parts":[[2014,12,1]]}},"URL":"https:\/\/doi.org\/10.1309\/ajcptlbeu5bq8shn","relation":{},"ISSN":["1943-7722","0002-9173"],"issn-type":[{"value":"1943-7722","type":"electronic"},{"value":"0002-9173","type":"print"}],"subject":[],"published-other":{"date-parts":[[2014,12,1]]},"published":{"date-parts":[[2014,12,1]]}}}